PERCEPTIVE ADVISORS LLC 13D and 13G filings for Soleno Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-19 9:44 pm Sale |
2024-11-14 | 13D | Soleno Therapeutics, Inc. SLNO |
PERCEPTIVE ADVISORS LLC | 1,770,792 4.100% |
-1,684,184 (-48.75%) |
Filing |
| 2024-11-14 4:30 pm Purchase |
2024-08-07 | 13D | Soleno Therapeutics, Inc. SLNO |
PERCEPTIVE ADVISORS LLC | 3,454,976 8.800% |
380,434 (+12.37%) |
Filing |
| 2023-10-23 4:20 pm Unchanged |
2023-10-20 | 13D | Soleno Therapeutics, Inc. SLNO |
PERCEPTIVE ADVISORS LLC | 3,074,542 10.100% |
0 (Unchanged) |
Filing |
| 2023-09-28 9:51 pm Purchase |
2023-09-26 | 13D | Soleno Therapeutics, Inc. SLNO |
PERCEPTIVE ADVISORS LLC | 3,074,542 23.700% |
866,789 (+39.26%) |
Filing |
| 2023-08-15 4:15 pm Unchanged |
2023-08-15 | 13D | Soleno Therapeutics, Inc. SLNO |
PERCEPTIVE ADVISORS LLC | 2,207,753 22.100% |
0 (Unchanged) |
Filing |
| 2023-06-06 4:17 pm Purchase |
2023-06-02 | 13D | Soleno Therapeutics, Inc. SLNO |
PERCEPTIVE ADVISORS LLC | 2,207,753 27.000% |
178,298 (+8.79%) |
Filing |
| 2023-05-30 4:15 pm Purchase |
2023-05-26 | 13D | Soleno Therapeutics, Inc. SLNO |
PERCEPTIVE ADVISORS LLC | 2,029,455 24.800% |
85,000 (+4.37%) |
Filing |
| 2023-05-25 4:58 pm Purchase |
2023-05-23 | 13D | Soleno Therapeutics, Inc. SLNO |
PERCEPTIVE ADVISORS LLC | 1,944,455 23.800% |
80,000 (+4.29%) |
Filing |
| 2023-05-18 4:32 pm Purchase |
2023-05-11 | 13D | Soleno Therapeutics, Inc. SLNO |
PERCEPTIVE ADVISORS LLC | 1,864,455 22.800% |
1,864,455 (New Position) |
Filing |